Institut Cancerologie De L'ouest

This first-in-human study is testing a new treatment called ATO-101™ for people with a specific type of bladder cancer that has not responded to standard therapies. The treatment involves placing a radioactive antibody directly into the bladder to target and destroy cancer cells …

This early study aims to find the maximum safe amount of tumor volume that can be treated with precise, high-dose radiation in men whose prostate cancer has spread to bones or lymph nodes and has stopped responding to standard treatments. Researchers will carefully increase the r…

This study is testing whether analyzing cancer DNA in urine can help doctors monitor prostate and bladder cancer without invasive procedures. Researchers will collect urine samples from 25 patients at different points during their standard cancer treatments to see if the test wor…